alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Clinical trials

Clinical trials

Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.

If you are thinking about joining a trial

A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.

Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.

Clear filters Download all 7,816 as CSV

"Open to new participants" means the registry status is RECRUITING or NOT_YET_RECRUITING — 1,523 of the 7,816 records. That is what the sponsor last told the registry, which can be months out of date.
Location is by country. This pull of the registry records the countries a study runs in, not its individual sites, so we cannot filter by US state or city — and we are not going to guess one. To find the nearest site, open a trial's record below: the official page lists every location with its contact details.

Showing 5,101–5,125 of 7,816 matching trials · page 205 of 313, 25 per page.

Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.

Registered Alzheimer's clinical trials. Every ID links to its official ClinicalTrials.gov record.
Trial Phase Status Enrolled Sponsor Last updated
Safety and Tolerability of Repeated Subcutaneous Injections of CAD 106 in Mild Alzheimer's Patients
NCT00795418
Placebo; CAD106
Runs in: United States · 10 sites 		PHASE2
other		 COMPLETED 31 Novartis
INDUSTRY		 2020-12-17
To Investigate the Safety and Tolerability of Repeated Subcutaneous Injections of CAD106 in Alzheimer's Patients
NCT01023685
CAD106
Runs in: United States · 8 sites 		PHASE2
other		 COMPLETED 24 Novartis
INDUSTRY		 2020-12-17
International Substudy Enigma2 on Postoperative Cognitive Disorders
NCT02489097
Nitrous Oxide; Placebo
Runs in: China; Switzerland · 2 sites 		PHASE4
other		 TERMINATED 140 University Hospital, Geneva
OTHER		 2020-12-16
[18F]THK-5351 Positron Emission Computed Tomography Study of Normal, Mild Cognitive Impairment, Alzheimer's Disease and Other Neurodegenerative Disease
NCT02656498
[18F]THK-5351
Runs in: South Korea · 2 sites 		PHASE2
other		 COMPLETED 135 Jae Seung Kim
OTHER		 2020-12-14
A Phase I [18F]THK-5351 Positron Emission Tomography Study in Healthy Subjects and Alzheimer's Disease
NCT03112096
[18F]THK-5351
Runs in: South Korea · 1 site 		PHASE1
other		 COMPLETED 12 Asan Foundation
OTHER		 2020-12-14
Evaluation of [18F]PI-2620 as a Potential Positron Emission Computed Tomography Radioligand for Imaging Tau Protein in the Brain
NCT03510572
[18F]PI-2620
Runs in: South Korea · 1 site 		EARLY_PHASE1
other		 COMPLETED 20 Asan Medical Center
OTHER		 2020-12-14
Aggression Prevention Training for Caregivers of Persons With Dementia (APT)
NCT02380703
Aggression Prevention Training (APT); Enhanced Usual Primary Care (EU-PC) 		NA
other		 COMPLETED 239 Baylor College of Medicine
OTHER		 2020-12-11
Mycose AdminiStration for HealIng Alzheimer NEuropathy (MASHIANE)
NCT04663854
Trehalose
Runs in: Iran · 1 site 		PHASE1
other		 UNKNOWN 20 Mashhad University of Medical Sciences
OTHER		 2020-12-11
An Individualized Exergame Training Solution for People With Major Neurocognitive Disorder: a Usability Study
NCT04664920
exergame
Runs in: Belgium · 1 site 		NA
other		 COMPLETED 22 Davy Vancampfort
OTHER		 2020-12-11
Acceptance and Commitment Therapy for Family Caregivers of People With Dementia
NCT04458870
Acceptance and Commitment Therapy
Runs in: United States · 1 site 		NA
other		 COMPLETED 7 University of Alabama at Birmingham
OTHER		 2020-12-10
A Phase I Study for Safety and Tolerability of AL002.
NCT03635047
AL002; Saline Solution
Runs in: Australia; United Kingdom; United States · 6 sites 		PHASE1
other		 COMPLETED 69 Alector Inc.
INDUSTRY		 2020-12-09
Predictors for Poststroke Outcomes: Tel Aviv Brain Acute Stroke Cohort Acute Stroke Cohort (TABASCO)
NCT01926691
Runs in: Israel · 1 site 		NA
other		 COMPLETED 575 Eli Sprecher, MD
OTHER_GOV		 2020-12-07
Guilt Focused Psychological Intervention
NCT04656808
Guilt Focused Intervention; Cognitive behavioral therapy
Runs in: Spain · 1 site 		NA
other		 TERMINATED 110 Universidad Rey Juan Carlos
OTHER		 2020-12-07
Doxycycline and TUDCA in Patients With Transthyretin Amyloid Cardiomyopathy
NCT01855360
Tauroursodeoxycholic Acid and Doxycycline
Runs in: United States · 1 site 		PHASE1|PHASE2
other		 COMPLETED 40 Brigham and Women's Hospital
OTHER		 2020-12-04
A Trial of Cilostazol in Patients With Mild Cognitive Impairment (COMCID)
NCT02491268
Cilostazol; Placebo
Runs in: Japan · 1 site 		PHASE2
other		 COMPLETED 166 National Cerebral and Cardiovascular Center, Japan
OTHER		 2020-12-04
Cognitive Outcomes During COVID-19 confiNemeNt in Elderly and Their Caregivers Using Technologies for DEMentia
NCT04385797
Telephone interview
Runs in: Spain · 1 site 		NA
other		 UNKNOWN 200 Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud
OTHER		 2020-12-04
Driving Evaluation and Fitness for Persons With Cognitive Impairments
NCT04648735
driving evaluation and practice 		NA
other		 COMPLETED 41 National Cheng Kung University
OTHER		 2020-12-04
Retinal Abnormalities as Biomarker of Disease Progression and Early Diagnosis of Parkinson Disease
NCT02640339
Runs in: United States · 1 site 		NA
other		 COMPLETED 166 NYU Langone Health
OTHER		 2020-12-02
Comparison Study of the Different Abbreviated Versions of the Geriatric Depression Scale
NCT04180683
Battery of screening tests with semi-structured interview; Battery ...
Runs in: Portugal · 32 sites 		NA
other		 COMPLETED 331 Rsocialform - Geriatria, Lda
OTHER		 2020-12-01
The Influence of GINkGo Biloba on the Pharmacokinetics of the UGT Substrate raltEgraviR (GINGER)
NCT01246804
raltegravir single dose; ginkgo biloba multiple dose
Runs in: Netherlands · 1 site 		PHASE1
other		 COMPLETED 18 Radboud University Medical Center
OTHER		 2020-11-30
Rapid Agitation Control With Ketamine in the Emergency Department
NCT03375671
Ketalar; Midazolam injection; Haloperidol
Runs in: Canada · 1 site 		PHASE2
other		 COMPLETED 81 David Barbic
OTHER		 2020-11-30
Impact of Hypno-analgesia on Pain During a Lumbar Puncture for Diagnosis of Alzheimer's Disease
NCT03352024
Relational care; Hypno-analgesia 		NA
other		 WITHDRAWN 0 University Hospital, Montpellier
OTHER		 2020-11-24
Clinical Trial of the Immunogenicity, Safety, and Efficacy of the Gam-COVID-Vac Vaccine Against COVID-19 in Venezuela
NCT04642339
Gam-COVID-Vac; Placebo 		PHASE3
other		 UNKNOWN 2,000 Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation
OTHER		 2020-11-24
A Randomized, Double-blind, Placebo-controlled, Combined Single Ascending Dose and Multiple Ascending Dose Study
NCT01230853
Active Comparator: A; Placebo Comparator B; Active Comparator B; Pl...
Runs in: United States · 8 sites 		PHASE1
other		 COMPLETED 80 Eisai Inc.
INDUSTRY		 2020-11-23
Downmodulating Monocyte Activation for HIV-1 Associated Neurocognitive Disorders (HAND)
NCT01600170
Atorvastatin (generic Lipitor); placebo
Runs in: United States · 1 site 		PHASE4
other		 COMPLETED 11 University of Pennsylvania
OTHER		 2020-11-23

This table is wider than a phone screen — swipe it sideways to see the rest.

Where these trials come from

Registry
ClinicalTrials.gov, pulled through their public API (v2)
Trials in the file
7,816
Source file
trials.csv (3.8 MB, 7816 rows)
Basis
Measured These are registry records as submitted by each study's sponsor.

What could make this misleading

Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.

Always check the official record before acting on anything here. This is a summary, not medical advice.

Related evidence Treatments → What the drugs that finished their trials actually achieved.

From the research library

The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.

Clinical trials

All 162 studies on Clinical trials →